Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Renner, W; Langsenlehner, U; Langsenlehner, T.
The Functional Erythropoetin rs1617640 Gene Polymorphism does not Affect Life Expectancy of Patients with Peripheral Arterial Disease
REV CARDIOVASC MED. 2023; 24(7): Doi: 10.31083/j.rcm2407199
Web of Science FullText FullText_MUG

 

Leading authors Med Uni Graz

Renner Wilfried

Co-authors Med Uni Graz

Langsenlehner Tanja

Langsenlehner Uwe

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

Background: A common functional variant (c.-1306A>C, rs1617640) in the gene encoding erythropoietin (EPO) has been linked to expression of erythropoietin and markers of erythropoiesis. Aim of the current study was the analysis of the role of this polymorphism for long term survival of patients with peripheral arterial disease (PAD). Methods: EPO genotypes as well as biomarkers for erythropoiesis were analyzed in a cohort of 946 patients with PAD. Survival follow-up was performed 20 years af-ter recruitment of patients. Results: Twenty years after recruitment, 752 (79.5%) patients were dead, 103 (10.9%) were still alive, and 91 (9.6%) were lost-to-follow up. In a Cox regression analysis including smoking habit, sex, type-2 diabetes, hypercholesterolemia and arterial hypertension, EPO genotypes were not associated with overall survival (Hazard ratio 0.63; 95% confidence interval 0.88-1.08, p = 0.63). Conclusions: The functional EPO rs1617640 gene polymorphism, irrespective of its association with markers of erythropoiesis, does not affect survival of PAD patients.

Find related publications in this database (Keywords)

erythropoietin

peripheral artery disease

genetics

survival

epidemiology

© Med Uni Graz • Imprint